Received Aug 11, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
patient got the first back in 2020; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a male patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (patient got the first back in 2020). On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced incomplete course of vaccination (Verbatim: patient got the first back in 2020). The outcome of the incomplete course of vaccination was not applicable. Additional Information: GSK receipt date: 31-JUL-2025 Other HCP reported that the second dose of Shingrix after the patient got the first back in 2020. She only provided patient's gender for adverse event details. Transfer to second line was made. Till the time of reporting patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination. This case is liked with US2025099401 reported by same reporter.; Sender's Comments: US-GSK-US2025099401: